Welcome to the InfoSci Platform
Internationalization Strategies of Chinese Pharmaceutical Firms

Internationalization Strategies of Chinese Pharmaceutical Firms

Xiaohui Li, Yunshan Lian, Jingyuan Zhao
Copyright: © 2013 |Volume: 4 |Issue: 4 |Pages: 13
ISSN: 1947-9638|EISSN: 1947-9646|EISBN13: 9781466635470|DOI: 10.4018/ijabim.2013100103
Cite Article Cite Article

MLA

Li, Xiaohui, et al. "Internationalization Strategies of Chinese Pharmaceutical Firms." IJABIM vol.4, no.4 2013: pp.35-47. http://doi.org/10.4018/ijabim.2013100103

APA

Li, X., Lian, Y., & Zhao, J. (2013). Internationalization Strategies of Chinese Pharmaceutical Firms. International Journal of Asian Business and Information Management (IJABIM), 4(4), 35-47. http://doi.org/10.4018/ijabim.2013100103

Chicago

Li, Xiaohui, Yunshan Lian, and Jingyuan Zhao. "Internationalization Strategies of Chinese Pharmaceutical Firms," International Journal of Asian Business and Information Management (IJABIM) 4, no.4: 35-47. http://doi.org/10.4018/ijabim.2013100103

Export Reference

Mendeley
Favorite Full-Issue Download

Abstract

Chinese pharmaceutical market value is about USD 110 billion in 2009, and it has become the world’s second largest market. Chinese pharmaceutical firms are becoming a growing player in global pharmaceutical chains. In this paper, sample firms are selected and surveyed with a focus on effective internationalization strategies and paths, through an empirical research, this paper summarizes the internationalization of Chinese pharmaceutical firms, and finds the effective strategies of international market entry are product upgrading along the industrial chains, international certification and cooperation, outsourcing and licensing, and other paths of overseas expansion. The implication for pharmaceutical firms in emerging market is to choose the suitable strategies based on own advantages, learn from the experience of other emerging market and domestic leading companies of internationalization, and gradually enter the standard market. This study not only provides international market entry strategies for the latecomers of Chinese pharmaceutical firms, but also enriches the internationalization theory of emerging market.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.